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University of California, Los Angeles, CaliforniaABSTRACT The liver plays a central role in maintaining whole body metabolic and energy homeostasis by consuming and
producing glucose and fatty acids. Glucose and fatty acids compete for hepatic substrate oxidation with regulation ensuring
glucose is oxidized preferentially. Increasing fatty acid oxidation is expected to decrease lipid storage in the liver and avoid
lipid-induced insulin-resistance. To increase hepatic lipid oxidation in the presence of glucose, we previously engineered
a synthetic glyoxylate shunt into human hepatocyte cultures and a mouse model and showed that this synthetic pathway
increases free fatty acid b-oxidation and confers resistance to diet-induced obesity in the mouse model. Here we used ensemble
modeling to decipher the effects of perturbations to the hepatic metabolic network on fatty acid oxidation and glucose uptake.
Despite sampling of kinetic parameters using the most fundamental elementary reaction models, the models based on current
metabolic regulation did not readily describe the phenotype generated by glyoxylate shunt expression. Although not conclusive,
this initial negative result prompted us to probe unknown regulations, and malate was identiﬁed as inhibitor of hexokinase 2
expression either through direct or indirect actions. This regulation allows the explanation of observed phenotypes (increased
fatty acid degradation and decreased glucose consumption). Moreover, the result is a function of pyruvate-carboxylase, mito-
chondrial pyruvate transporter, citrate transporter protein, and citrate synthase activities. Some subsets of these ﬂux ratios
predict increases in fatty acid and decreases in glucose uptake after glyoxylate expression, whereas others predict no change.
Altogether, this work deﬁnes the possible biochemical space where the synthetic shunt will produce the desired phenotype and
demonstrates the efﬁcacy of ensemble modeling for synthetic pathway design.INTRODUCTIONObesity is a global health concern of escalating proportions
(1,2) and is ultimately caused by an energy imbalance.
Obesity is typically associated with elevated levels of plasma
free fatty acids and triglycerides (3), a result of both exces-
sive intake and de novo synthesis. This often leads to fatty
acid storage in peripheral tissues such as the liver which
results in the comorbidities associated with the metabolic
syndrome including cardiovascular disease and insulin resis-
tance (4–7). This suggests that increasing hepatic free fatty
acid oxidation may improve the metabolic profile of obese
patients.
Fatty acid oxidation is regulated such that glucose is
oxidized preferentially (8). High plasma glucose levels are
associated with increased hepatic glycolytic rates and ele-
vated levels of mitochondrial citrate. Fatty acid biosynthesis
is initiated by citrate transporter protein (CTP) transport of
citrate from the mitochondria to the cytosol (Fig. 1, A and B).
Acetyl-CoA, a product of ATP citrate lyase, is then con-
verted to malonyl-CoA by acetyl-CoA carboxylase, and
malonyl-CoA is used as a precursor for fatty acid synthesis
via fatty acid synthase. In addition to the role in de novo fatty
acid synthesis, malonyl-CoA also serves as a key regulator of
fatty acid oxidation through allosteric inhibition of the
mitochondrial fatty acid transporter carnitine palmitoyl-Submitted July 9, 2009, and accepted for publication December 11, 2009.
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0006-3495/10/04/1385/11 $2.00transferase 1a (CPT1a) (8,9). This regulation ensures that
fatty acids are excluded from the mitochondria when
malonyl-CoA level is high. Conversely, fatty acid oxidation
proceeds when glucose, and thus malonyl-CoA levels, are
decreased. Fatty acid oxidation occurs in the mitochondria
to generate acetyl-CoA and reducing equivalents (Fig. 1 C).
We have previously shown that liver-specific expression
of the nonnative two-enzyme glyoxylate pathway, isocitrate
lyase (ACEA) and malate synthase (ACEB), increases fatty
acid oxidation and confers resistance to diet-induced obesity
in C57BL/6 mice (10). This pathway creates an additional
channel for fatty acid oxidation and decreases malonyl-
CoA levels, a fatty acid oxidation inhibitor. Additionally,
mice expressing the glyoxylate shunt in the liver accumulate
significantly less fat mass on a high fat diet than the control
mice and exhibit decreased plasma triglyceride levels.
A human hepatocyte HepG2 cell line expressing the
glyoxylate shunt (designated ACE) was also found to have
increased fatty acid degradation and decreased glucose
uptake compared to wild-type (WT) cells (Fig. 2, A and B).
Based on pathway stoichiometry, the resulting phenotype
from glyoxylate shunt expression cannot be predicted: it
may increase, decrease, or have no effect on fatty acid degra-
dation depending on how the pathway integrates into the
native metabolic and regulatory networks. The first possi-
bility is that carbon conserved from the glyoxylate shunt
may be incorporated into mitochondrial citrate, and trans-
ported out of the mitochondria for fatty acid synthesis.doi: 10.1016/j.bpj.2009.12.4308
FIGURE 1 (A) The hepatocyte metabolic network considered for EM anal-
ysis included 85 reactions, 85 metabolites, glycolysis, TCA cycle, fatty acid
synthesis and degradation, anaplerotic reactions, and compartmentalized
ATP and cofactors. (B) Fatty acid synthesis occurs in the cytosol and begins
with condensation of acetyl-CoA and malonyl-CoA to Acetoacetyl ACP. (C)
Fatty acid degradation takes place exclusively in the mitochondria and is
inhibited by malonyl-CoA, an intermediate in fatty acid biosynthesis. Fatty
acid oxidation generates reducing power and mitochondrial acetyl-CoA.
1386 Dean et al.This cycle results in malonyl-CoA production and is
expected to inhibit fatty acid degradation. The second possi-
bility is that the tricarboxylic acid cycle (TCA) cycle inter-Biophysical Journal 98(8) 1385–1395mediates can be conserved by the glyoxylate shunt and
used as gluconeogenesis substrate. This route is used by
plants and bacteria for growth with fatty acids as the carbon
source. Alternatively, an option exists where the conserved
carbon is shuttled out of the mitochondria as malate and
oxidized to pyruvate through cytosolic malic enzyme
(ME1). These enzymes form an additional cycle for acetyl
CoA oxidation (11,12).
The general aim of this study is to further investigate the
effect of hepatic glyoxylate shunt expression and gain further
insight into hepatic fatty acid metabolism, and for this
purpose we used a mathematical approach termed ensemble
modeling (EM) (13). Predicting the effect of perturbations
such as an overexpression or knockdown on a metabolic
network is often nontrivial because of interconnected
enzymatic reactions, cofactor balancing, and regulations
(12,14–17). Mathematical analysis has proven to be a useful
tool in the study of metabolic networks (12,18–22) and liver
metabolism (23–26). The modeling approach allows for
greater understanding of metabolism and may ultimately
serve as a platform for predicting genotype-phenotype rela-
tionships and targets for driving metabolism to a desired
state, or in this case, targets for obesity management.
In EM, the enzymatic reactions of the metabolic network
are formulated as elementary reactions and parameters are
sampled under the thermodynamic and steady-state con-
straints. As data available are insufficient to define kinetic
parameters uniquely, all parameter sets that describe the
available data are retained in the ensemble and screened
with available data. Each parameter set is called a model.
By introducing a perturbation to the metabolic network
and determining the resulting behavior, we are able to screen
the models according to previously determined experimental
data or make predictions for future experimental tests under
the known mechanistic framework.
In this work, we ask the question: is the current metabolic
mechanism sufficient to explain the phenotype (increased
fatty acid degradation and decreased glucose consumption)
and if so, is there any particular range of parameters suitable
to explain the phenotype? As we do not have kinetic para-
meters, nor do we have data in the transient state, our models
are constrained by the only known data, steady-state fluxes
for the reference state (control cells). EM allows us to create
an ensemble of models that essentially span all kinetic
space based on the currently known metabolic mechanism
but are constrained to the same known steady state. It should
be noted that the steady state of the perturbation (engineered
cells) depends on kinetic parameters in the reference
(control) cells. Thus, the steady-state phenotype after pertur-
bation can be used to screen for allowable or exclude unal-
lowable parameter regions. The allowable parameter regions
explain the phenotype based on current mechanisms, and
provide the hypotheses to be tested further.
Interestingly, we show that the currently available mecha-
nisms do not readily explain the observed increased fatty
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FIGURE 2 (A) We have previously shown that a human hepatocyte
HepG2 cell line expressing the glyoxylate shunt (ACE) exhibits increased
fatty acid uptake and decreased glucose uptake and lactate production.
(B) The percentage change in extracellular fluxes due to glyoxylate shunt
Ensemble Modeling of Hepatic Glyoxylate Shunt Expression 1387acid degradation and decreased glucose consumption in
ACE cells, regardless of extensive parameters sampled.
This result prompted us to investigate regulation of glucose
metabolism by metabolites related to glyoxylate shunt.
Indeed, we found that malate decreased hexokinase 2 (HK2)
expression using reverse transcription-polymerase chain
reaction (RT-PCR). By incorporating this novel observation,
we show that some of the models in the ensemble were able
to describe the observed perturbation phenotypes. However,
the success of the model depends on the two split ratios in
two branched points. If these parameters are far from the
allowable region, the currently available mechanism with
the malate-HK2 regulation cannot explain the observed
phenotype after glyoxylate shunt introduction. These split
ratio ranges, although fuzzy, constitute a new hypothesis
for further investigation.MATERIALS AND METHODS
Stable cell line generation and cell culture
Human hepatoma cell line, HepG2 (American Type Culture Collection,
Manassas, VA), was maintained in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% heat-inactivated fetal bovine serum
(FBS) and 50 mg/mL penicillin, 50 mg/mL streptomycin, and 100 mg/mL
neomycin at 37C in a humidified atmosphere containing 5% CO2. Cells
were stably transfected with a pBudACEAB (10), a vector containing
ACEA and ACEB fused to mitochondrial leader sequences, as previously
described (10).
Metabolite quantiﬁcation
Metabolites were quantified as previously described (10). In brief, 16 h
before uptake assays, cells were seeded 1.75  105 cells/well in 24-well
multi-plates containing DMEM supplemented with 10% FBS. Cells were
washed with phosphate-buffered saline (PBS) and then incubated in
1.5 mL of DMEM media enriched with 300 mM palmitate and 25 mM
glucose, and media samples were collected after 4 h. After incubation,
metabolites were quantified and total protein was assayed by the method
of Bradford (27).
Reverse-transcriptase polymerase chain reaction
(RT-PCR)
Sixteen hours before reverse transcription-polymerase chain reaction
(RT-PCR) assay, 2.5  106 cells were plated in 60-mM plates. For HK2
expression studies, cells were washed 3 with PBS and cells were incubated
in DMEM containing 10% FBS and various concentrations of either malate
or succinate for 3.5 h. It has previously been shown that TCA cycle interme-
diates, including malate (28,29) and succinate (30), are readily transported
intracellularly. After incubation, cells were washed 3 with PBS, and RNA
was isolated using RNeasy columns (Qiagen, Valencia, CA). First-strandperturbation. (C) Achievable combinations of PC/PYRT split ratio and
CTP/CS split ratio are shown in the shaded region, whereas the unachievable
combinations are in the open region. Twenty-five combinations used in the
simulation are marked by a solid square. (D) Malate inhibition of HK2 must
be included in the model to accurately predict ACE phenotype. HK2 gene
expression as a function of extracellular malate. Extracellular malate was
found to decrease HK2 expression. Mean 5 SE; n ¼ 3. Asterisk symbol
indicates p < 0.05 compared to 0 mM malate.
Biophysical Journal 98(8) 1385–1395
TABLE 1 Metabolite abbreviations used for the hepatic
metabolic network in Fig. 1 A
Glycolysis and TCA cycle
Metabolite abbreviation Metabolite name
Glcext Extracellular glucose
1388 Dean et al.cDNA was synthesized using 300 ng of RNA and Superscript III Reverse
Transcriptase (Invitrogen, Carlsbad, CA). Quantitative RT-PCR was per-
formed using SYBR Green chemistry, Quantitect primer set (Qiagen), and
Smart Cycler (Cepheid, Sunnyvale, CA) with the following cycling
executed 40 times: 95C (10 s)/ 55C (30 s)/ 72C (8-s data collection).
Fold changes were calculated using DDCt method (31) with b-actin as an
endogenous control.
Glcint Intracellular glucose
G6P Glucose-6-phosphate
F6P Fructose-6-phosphate
F,1,6,BP Fructose-1,6-biphosphate
DHAP Dihydroxyacetone phosphate
GAP D-Glyceraldehyde-3-phosphate
1,3,DPG 1,3-Diphosphate glycerate
3PG 3-Phospho-D-glycerate
2PG 2-Phospho-D-glycerate
PEP Phosphoenolpyruvate
PYRc Cytosolic pyruvate
LACc Cytosolic lactate
LACext Extracellular lactate
OAAc Cytosolic oxaloacetate
CITc Cytosolic citrate
MALc Cytosolic malate
ACOAc Cytosolic acetyl-CoA
MCOA Malonyl-CoA
FAc Cytosolic palmitate
FAext Extracellular palmitate
PYRm Mitochondrial pyruvate
ACOAm Mitochondrial acetyl-CoA
OAAm Mitochondrial oxaloacetate
CITm Mitochondrial citrate
FAm Mitochondrial palmitate
CIS-ACO Cis-aconitate
ICIT Isocitrate
2-KG 2-Ketoglutarate
SUCC-COA Succinyl-CoA
FUM Fumarate
MALm Mitochondrial malate
GLYX GlyoxylateOverview of ensemble modeling (EM)
Complete modeling of metabolic networks requires full sets of kinetic
parameters and experimental data for validation. As we do not have kinetic
parameters and the available data are too scarce to estimate parameters in
a meaningful way, we used EM to examine the consistency between the
known mechanisms and experimental data. The goal of EM is to develop a
set of kinetic models with the same structure but different kinetic parameters
such that these models (with different parameters) all reach the same steady
state (13,32,33). If the general model is described as the following set of
nonlinear ordinary differential equations,
dxi
dt
¼
X
niðx; kÞ 
X
njðx; kÞ; (1)
where vi and vj are the enzyme kinetic functions (i, production, j, consump-
tion of species xi), then the problem can be stated mathematically as deter-
mining or sampling all the kinetic parameters k, such that
nðxss; kÞ ¼ nrefnet; (2)
where nrefnet is the net steady-state flux (known) for each enzyme in the refer-
ence cell, and xss is the steady-state concentration of the metabolite species.
The major difficulty of this problem is that the constrained sampling of k to
satisfy Eq. 2 is time-consuming for general nonlinear functions. EM circum-
vents such a hurdle by using elementary reaction schemes, which are the
most fundamental description of enzyme kinetics and follow mass-action
kinetics. The log-linear property of mass-action kinetics provides us a plat-
form for efficient constrained sampling of k and network scale-up. As the
elementary reactions are all thermodynamically reversible, details of
handling unidirectional fluxes will be described shortly.
This ensemble of models represents all possible kinetics given the same
steady-state flux and kinetic mechanisms. Once the initial ensemble of
models is constructed, each one of them is perturbed the same way as in
the experiments. In this case, the glyoxylate shunt enzymes in the model
are elevated in the model, as in the experiment. One then re-solves the ordi-
nary differential equations using the same parameter sets, but with overex-
pressed glyoxylate shunt enzymes. The models that predict the experimental
data (increased fatty acid degradation and decreased glucose consumption
flux) after the glyoxylate shunt expression are retained. The process can
be repeated when more data are available. Note that this strategy does not
aim at estimating the best-fit parameters, because of the scarcity of data.
Instead, it examines the possible matching between models with currently
known mechanisms and experimental data.TABLE 2 Metabolite abbreviations used for the fatty acid
synthesis and degradation pathways in Fig. 1, B and C
Fatty acid synthesis and degradation
Metabolite abbreviation Metabolite name
A-ACP Acetoacetyl ACP
D-ACP D-3-hydroxybutyryl ACP
B-ACP Butyryl ACP
FA-CoA Fatty acid-CoA
FA-CRNc Mitochondrial fatty acid-carnitine
FA-CRNm Cytosolic fatty acid-carnitine
A-CoA Acyl-CoA
3-KA 3-ketoacyl-CoADetermination of steady-state reference ﬂux
A network consisting of 85 metabolites and 85 reactions was used to model
hepatic metabolism (see Fig. 1, A–C; Tables 1–3; Table S1, Table S2,
Table S3, Table S4, and Table S5 in the Supporting Material). Metabolite
concentration data for glucose uptake, lactate production, and fatty acid
uptake was used to determine the steady-state internal flux distribution
(Fig. 2, A and B). Steady-state fluxes were calculated by setting Eq. 1 to
zero. To solve for remaining degrees of freedom, we varied the split ratio
of citrate transporter protein (CTP)/citrate synthase (CS) and pyruvate
carboxylase (PC)/pyruvate mitochondrial transporter (PYRT) and solved
for the internal fluxes. Because Eq. 1 has no solution for certain combina-
tions of these two split ratios, the upper and lower boundaries of allowableBiophysical Journal 98(8) 1385–1395split ratios were first identified (Fig. 2 C). Once the boundaries of allowable
split ratios were determined, external metabolite production data was
combined with various split ratios and Eq. 1 was solved for within the allow-
able split-ratio subset area. When solving for internal steady-state reference
fluxes, flux through the glyoxylate shunt was initially set to ~2% of the
measured glucose uptake because hepatocytes have previously been shown
to have low glyoxylate shunt activity under certain conditions (34,35). Even
though these intrinsic activities are still debatable, 2% flux does not change
the conclusion and accounts for possible intrinsic glyoxylate shunt activities
reported previously (31,32).
TABLE 3 Regulation included in network
Enzyme Regulatory metabolite
Activator(þ)/
inhibitor()
Phosphofructokinase Cytosolic citrate 
Pyruvate dehydrogenase Mitochondrial acetyl-CoA 
Carnitine
palmitoyl-transferase 1a
Malonyl-CoA 
Hekokinase2 Cytosolic malate 
Ensemble Modeling of Hepatic Glyoxylate Shunt Expression 1389Constructing an ensemble of models
As stated above, EM models enzymatic reactions as basic elementary reac-
tions that follow mass-action kinetics. The conversion of metabolite i to iþ1
by enzyme Ei is
Xi4
Ei
Xiþ 1: (3)
This can be described in terms of six elementary reactions as
Xi þ Ei%
ni;1
ni;2
Step 1
XiEi%
ni;3
ni;4
Step 2
Xiþ 1Ei%
ni;5
ni;6
Step 3
Xiþ 1 þ Ei; (4)
where each elementary reaction follows mass-action kinetics,
ni;1 ¼ ki;1½Xi½Ei; (5)
and where ki,1 is the rate constant of the forward reaction of step 1 of the
overall reaction catalyzed by the enzyme Ei, [Xi] is the concentration of
metabolite i, and [Ei] is the concentration of free enzyme i (Table S6).
Furthermore, the metabolite concentrations are normalized by the corre-
sponding concentration at the reference steady state Xss;refi;1 , and free enzyme
and enzyme complex concentrations are normalized by the corresponding
total enzyme concentration at the reference steady state E refi;total. Equation 5
can be written as follows, where ~K
ref
i;1 is the normalized rate constant:
ni;1 ¼

ki;1E
ref
i;totalX
ss;ref
i
  ½Xi
Xss;refi
 ½Ei
E refi;total
¼ ~Krefi;1  ~Xi  ~ei;1: (6)
At reference state,
~X
ss;ref
i h
Xss;refi
Xss;refi
¼ 1;
and the sum of different normalized complexed form ~erefi;j is 1.
The reversibility of the steady-state net fluxes is constrained thermody-
namically by Gibbs free energies. Each steady-state flux can be described
as a combination of forward and reverse reactions,
nrefi;2j1  nrefi;2j ¼ Vrefi;net; (7)
where nrefi;2j1 and n
ref
i;2j represent the forward and reverse reactions of step j
catalyzed by enzyme i, and the difference is the net flux determined previ-
ously. The reversibility is then defined as (13)
Ri;j ¼
min

ni;2j1; ni;2j

max

ni;2j1; ni;2j
; (8)
where Ri,j ¼ 0 for irreversible steps and 1 for a step at equilibrium. For the
overall reaction catalyzed by enzyme i, the reversibilities are constrained by
the Gibbs free energy,Xni
lnRi;j ¼ signðVi;netÞDGi; (9)
j¼ 1 RTwhere ni represents the number of elementary reactions for the overall
reaction catalyzed by enzyme i and a reaction with a positive (forward)
net flux has sign(Vi,net) ¼þ1 and a reaction with a negative net flux (reverse)
has a value of 1. Equation 9 ensures that the net flux for reaction i
will be positive if DGi < 0, but that the net flux will be negative if
DGi > 0. The exact values for Gibb’s free energies cannot be calculated
because they are a function of metabolite concentrations; therefore, we
calculate a range of reversibilities by allowing metabolite concentrations
to vary within a 100-fold change range. This yields a range of Gibbs free
energies:

DGi
RT

lower bound
%sign

Vrefi;net


X
j
ln Rrefi;j%ð
DGi
RT
Þupper bound: (10)
Additionally, the fractions of bound and free forms of enzyme i are sampled
such that their sum is equal to 1. There are many combinations of reversibil-
ities and enzyme fractions for each reference state. Once the reversibilities
and enzyme fractions are sampled, kinetic parameters are solved for from
the normalized version of Eq. 5. Each model thus contains kinetic parame-
ters that are defined from the reversibilities and enzyme fractions that were
sampled for that particular model and the entire ensemble of models reach
the same steady state as defined by the reference state. To study the effects
of glyoxylate shunt expression, ACEA and ACEB enzyme concentrations
were increased 10-fold.Screening of models by Michaelis-Menten
constant Km
In an effort to generate and retain models with physiologically relevant
kinetic parameters, we implemented an additional step to screen models
for experimentally determined Km values. Initially, an ensemble of 1  106
models were created for each reference state as described in Eqs. 1–10. A Km
value for the elementary reactions shown in Eq. 4 has been previously
derived (15) as
Kim ¼
ki;2ki;4 þ ki;2ki;5 þ ki;3ki;5
ki;1ðki;4 þ ki;3 þ ki;5Þ : (11)
Models matching experimentally determined Km values (with 25% toler-
ance) for glucose-6-phosphate isomerase (GPI, Km ¼ 0.445 mM), phospho-
glyceratemutase (PGAM, Km ¼ 0.22 mM), enolase (ENO, Km ¼ 0.30 mM),
and aconitase1 (ACO1, Km ¼ 0.30 mM) were retained and used for
analyzing the effect of glyoxylate shunt overexpression.RESULTS
The hepatocyte fatty acid metabolic network
A human HepG2 cell line was used in the study. The hepatic
metabolic network, shown in Fig. 1, A–C, contains 85
metabolites and 85 reactions and includes glycolysis, TCA
cycle, fatty acid synthesis and degradation, anaplerotic reac-
tions, and compartmentalized ATP and cofactors. Tables 1
and 2 contain a full description of all abbreviations used.
As flux through the pentose pathway has been shown to
be <5% of glucose uptake flux for the HepG2 cell line, it
was excluded from this model (36). Triglycerides and ketone
body formations were shown to be unchanged in the cell
cultures with or without the glyoxylate shunt expression.Biophysical Journal 98(8) 1385–1395
TABLE 4 Enzyme reaction mechanisms and inhibition were modeled as shown here
1 Substrate, 1 product
Xi þ Ei%
ni;1
ni;2
XiEi%
ni;3
ni;4
Xiþ1 þ Ei%
ni;5
ni;6
Xiþ1 þ Ei
1 Substrate, 2 products Xi þ Ei%
ni;1
ni;2
XiEi%
ni;3
ni;4
Xiþ1 þ Xiþ2 þ Ei%
ni;5
ni;6
Xiþ1 þ Xiþ2 þ Ei%
ni;7
ni;8
Xiþ2 þ Ei
2 Substrates, 1 product Xi þ Ei%
ni;1
ni;2
XiEi þ Xiþ1%
ni;3
ni;4
XiXiþ1Ei%
ni;5
ni;6
Xiþ2Ei%
ni;7
ni;8
Xiþ2 þ Ei
2 Substrates, 2 products Xi þ Ei%
ni;1
ni;2
XiEi þ Xiþ1%
ni;3
ni;4
XiXiþ1Ei%
ni;5
ni;6
Xiþ2Xiþ3Ei%
ni;7
ni;8
Xiþ2 þ Xiþ3Ei%
ni;9
ni;10
Xiþ3 þ Ei
Competitive inhibition
Xi þ Ei%
ni;1
ni;2
XiEi%
ni;3
ni;4
Xiþ1 þ Ei%
ni;5
ni;6
Xiþ1 þ Ei
þ
I
ni;7Y[ni;8
IEi
Noncompetitive inhibition
Xi þ Ei%
ni;1
ni;2
XiEi%
ni;3
ni;4
Xiþ1 þ Ei%
ni;5
ni;6
Xiþ1 þ Ei
þ
I
ni;9Y[ni;10
IXiIEi
1390 Dean et al.Thus, these pathways were not included in the model.
Additionally, allosteric regulation of PFK (37), PDH (38),
and CPT1a (9) enzymes was incorporated into the model
(Table 3). Allosteric regulation was incorporated into the
models as mixed inhibition, which includes both competitive
and uncompetitive inhibition (Table 4). Competitive inhibi-
tion refers to the case when inhibitor-enzyme binding pre-
vents substrate binding and uncompetitive inhibition occurs
when the inhibitor metabolite only binds to the enzyme-
substrate complex.
The human HepG2 cell line transfected with the control
gene (lacZ) was used as the reference state. The reference
states were generated through measurement of WT glucose
uptake, lactate production, and fatty acid uptake (Fig. 2, A
and B). The glyoxylate shunt flux was assigned to 2% of
glucose flux, as WT cells were found to have low basal
glyoxylate shunt enzyme activity (10). The remaining
degrees of freedom were examined by varying the CTP/CS
and PC/PYRT split ratios. These split ratios define the space
within which we examine the effect of introducing the glyox-
ylate shunt genes into the cell. As solutions for the steady
state were unachievable for certain combinations of split
ratios (Eq. 1), the upper limits and boundaries of allowable
split ratios were first identified. Unachievable split ratio
combinations are shown in the open region in Fig. 2 C,
whereas achievable combinations are shown in the shaded
region. Once the boundaries for achievable split ratios
were identified, 25 sets of reference steady-state fluxes were
generated based on external metabolite measurements and
the split ratio of interest. Reference states were chosen
with split ratio combinations from the border of the allow-
able split ratio area as well as with split ratio combinations
from within the allowable area.Biophysical Journal 98(8) 1385–1395Screening of models based on experimentally
determined kinetic parameters
The reference state reactions were formulated as elementary
reactions (Eqs. 3–5) and reversibilities and enzyme fractions
were sampled for each reference state (Eqs. 6–10), thus
producing an ensemble of models for each reference state
within the allowable split ratio area. For this analysis, 106
models were initially generated for each reference state.
After ensuring that the reversibilities were thermodynami-
cally compliant (Eqs. 9 and 10), kinetic parameters for the
elementary reactions were calculated for the models within
the ensemble for each reference state. The elementary reac-
tion kinetics can then be used to calculate the Michaelis-
Menten constant (Km). In an effort to retain models with
physiological relevance, we screened the 1  106 generated
models for those with experimentally determined Km values.
Specifically, models matching experimentally determined
Km values for glucose-6-phosphate isomerase (GPI), phos-
phoglyceratemutase (PGAM), enolase (ENO), and aconi-
tase1 (ACO1) were retained and used to analyze the effects
of glyoxylate shunt expression (discussed in detail below;
see Eq. 11). Typically ~150 models were retained out of
the initial 106 models screened. This process allowed us to
generate an ensemble of ~150 models for each reference state
within the allowable split ratio subset area.
Malate inhibits HK2 expression
To study the effect of glyoxylate shunt expression, the
enzyme concentrations of ACEA and ACEB were increased
10-fold and the new steady-state fluxes of each model
within each ensemble for each reference state were solved.
Unfortunately, even after screening for the Km values, the
FIGURE 3 EM was used to investigate the dependence of glyoxylate shunt expression on reference state for (A) fatty acid uptake, (B) glucose uptake, and
(C) lactate production. A subset of split ratios predicted increased fatty acid uptake and decreased glucose uptake after glyoxylate shunt expression, consistent
with experimental data, whereas others predicted no change. Open areas represent split ratio areas where reference steady state was unsolvable according to
Eq. 1. (D) The predicted change in CPT1a flux is dependent on the initial reference state. The predicted changes in CPT1a and fatty acid uptake were propor-
tional. (E) ME1 expression as a function of reference state. Our previous analysis implicated ME1 in a cycle for oxidation of acetyl-CoA. The predicted glucose
uptake after glyoxylate shunt expression was inversely related to the predicted change in ME1: a predicted increase in ME1 expression meant a predicted
decrease in glucose uptake. (F) ME1 flux % change as a function of glucose uptake % change for 148 models. Individual model results are shown as blue
triangles, whereas the average for the ensemble is represented as a red square.
Ensemble Modeling of Hepatic Glyoxylate Shunt Expression 1391resulting models could not describe the phenotype observed
(increased fatty acid degradation and decreased glucose con-
sumption) after introducing the glyoxylate shunt enzymes.
Even though we have not proven mathematically that no
feasible set of parameters exist to describe these data, the
initial negative result prompted us to look for novel meta-
bolic regulation that is not accounted for in the literature.
In an attempt to further understand the decreased glucose
uptake in ACE cells we tested candidate signaling metabo-
lites for effects on gene expression. Cells were incubated
in medium containing various concentrations of candidate
molecules for 3.5 h, after which RNA was harvested and
gene expression changes were determined by RT-PCR.
We found that addition of malate to the cell medium
decreased HK2 gene expression (Fig. 2 D). We also tested
the effects of other TCA metabolites on HK2 expression
and found a markedly smaller effect than that of malate on
HK2 expression. This demonstrates that although other
metabolites may influence gene expression, malate’s effect
is most pronounced.
As we do not know the detailed mechanism of this regu-
lation and as our model does not account for gene expression
changes at this time, we represented the malate inhibition asallosteric enzyme regulation (Table 4). This regulation is
then incorporated in the following studies.The effect of ACEA and ACEB expression
With the above malate-HK2 regulation in the models and
sampled kinetic parameters, the enzyme concentrations of
ACEA and ACEB were increased 10-fold and the new
steady-state fluxes of each model within each ensemble for
each reference state were solved. The predicted steady-state
flux for each reference state after ACEA and ACEB pertur-
bation was calculated as the average predicted steady-state
flux of all 150 models and a plot was generated for fluxes
using triangle-based linear interpolation (39). We found the
effect of glyoxylate shunt expression was a function of the
reference state PC/PYRT and CTP/CS split ratios (Fig. 3,
A–C). Specifically, we found that reference states with low
CTP/CS split ratios (<0.1) predicted no change in fatty
acid uptake after glyoxylate shunt expression (Fig. 3 A).
Conversely, reference states with PC/PYRT split ratios
between 0.3 and 0.7 and maximum allowable CTP/CS split
ratios, 0.2–0.5, predicted increases in fatty acid uptake after
glyoxylate shunt expression. The maximum predictedBiophysical Journal 98(8) 1385–1395
FIGURE 4 Malate inhibition of HK2 must be included in model to accurately predict ACE phenotype. Experimental data and EM prediction with and
without malate inhibition of HK2 for (A) fatty acid uptake, (B) glucose uptake, and (C) lactate production.
1392 Dean et al.increase, 58%, in fatty acid uptake occurred at a PC/PYRT of
0.5 and CTP/CS split ratio of 0.29. This predicted increase
was close to the 70% increase determined experimentally
(Fig. 2 B).
EM was also used to examine the effect of ACEA and
ACEB expression on glucose uptake (Fig. 3 B). Similar to
fatty acid uptake, we found that the effect of glyoxylate shunt
expression on glucose uptake was dependent on the initial
reference state and that multiple possibilities exist. Using
EM we found that a PC/PYRT split ratio region between
0.5 and 0.8 and CTP/CS split ratio between 0 and 0.2 pre-
dicted no change or an increase in glucose uptake after
glyoxylate shunt expression (Fig. 3 B). Interestingly, the
region which showed no change or an increase in glucose
uptake also showed no change in fatty acid uptake (Fig. 3
A). As the CTP/CS split ratio was increased, a decrease in
glucose uptake was predicted. Low (<0.1) PC/PYRT and
CTP/CS split ratio reference states were found to predict
>60% decrease in glucose uptake, a much greater decrease
than what was found experimentally (47% decrease, Fig. 2
B). The split ratio region (PC/PYRT: 0.5, CTP/CS: 0.29),
which predicted the highest and most accurate increase in
fatty acid uptake (Fig. 3 A), showed a 40% decrease in
glucose uptake after glyoxylate shunt expression (Fig. 3
B), which was also a close match to the experimentally deter-
mined value of 47% decrease (Fig. 2 B) We also looked at
the effect of glyoxylate shunt expression on lactate produc-
tion (Fig. 3 C). As previously documented (10), lactate
production was found to be proportional to glucose uptake
and a surface plot demonstrated that a predicted decrease
in lactate production was congruous with a predicted
decrease in glucose uptake, and vice versa.
The effect of glyoxylate shunt perturbation
on internal ﬂuxes CPT1a and ME1
We next examined the effect of glyoxylate shunt expression
on the internal fluxes CPT1a (Fig. 3 D) and cytosolic malic
enzyme (ME1) (Fig. 3 E). As expected based on analysis of
external uptake fluxes (Fig. 3, A–C), the change in theseBiophysical Journal 98(8) 1385–1395fluxes was found to be dependent on the initial reference
state. We found that reference states that predicted increases
in fatty acid uptake also predicted increases in CPT1a
flux (Fig. 3 D). As stated above, reference states with low
CTP/CS split ratios predicted no change in fatty acid uptake
after perturbation, and a similar trend was found when exam-
ining CPT1a. Interestingly, the reference state with the
highest predicted increase in CPT1a flux (PC/PYRT: 0.1,
CTP/CS: 0.1) was not the reference state with highest
predicted increase in fatty acid uptake. This can possibly
be explained by the fact that this reference state also pre-
dicted an increase in ACC flux, suggesting glyoxylate shunt
perturbation of this reference state generates a futile cycle
where fatty acids are concurrently synthesized and oxidized.
As we have previously shown that ACE cells use the
glyoxylate shunt and ME1 as an alternate cycle for complete
oxidation of acetyl-CoA to CO2 (10), we used EM to analyze
the effect of glyoxylate shunt expression on ME1 flux.
We found that the predicted change in ME1 flux was
inversely proportional to glucose uptake (Fig. 3, E and F):
reference states predicting increases in ME1 expression pre-
dicted decreases in glucose uptake. Similarly, we found that
reference states predicting increases in fatty acid uptake after
glyoxylate shunt perturbation predicted increases in ME1
expression. This trend was also found to be consistent at
the level of the individual model (Fig. 3 F). This analysis
demonstrates that ME1 flux is an integral component of
the phenotype generated by glyoxylate shunt expression.
Importance of malate-HK2 regulation
As discussed above, the malate-HK2 regulation (Fig. 2 D)
was essential in describing the observed phenotypes. This
suggests that the glyoxylate shunt may decrease glucose
uptake by generating additional malate through increased
ME1 flux. This is also seen in Fig. 3, E and F, where glucose
uptake was found to be inversely proportional to ME1 flux.
To test the hypothesis that ME1 flux and malate concentra-
tions inhibit glucose uptake we removed the allosteric
inhibition of HK2 by malate and analyzed the effects of
Km PGAM : 
14,045 
Km ENO : 
1,490 
Km GPI : 
168,629 
Inial: 
1,000,000 
A 
Km ACO1 
148 
0.1 
0.12 
0.14 
0.16 
0.18 
0.2 
0.22 
WT, exp EM, -Km  
Screen 
EM, +Km  
Screen 
A CE exp 
)
 
g
 
m
 
/ 
r
 
h
 
/ 
e
 
l 
o
 
m
 
u
 
(
 
  
e
 
k
 
a
 
t
 
p
 
U
 
  
d
 
i 
c
 
A
 
  
y
 
t
 
t
 
a
 
F
 
B 
C 
0 
5 
10 
15 
20 
25 
30 
35 
40 
s
 
l 
e
 
d
 
o
 
M
 
  f
 
o
 
  
r
 
e
 
b
 
m
 
u
 
N
 
EM, -Km Screen 
EM, +Km Screen 
0
 
-
 
0
 
2
 
-
 
0
 
2
 
-
 
0
 
0
 
4
 
-
 
0
 
2
 
0
 
6
 
-
 
0
 
4
 
0
 
8
 
-
 
0
 
6
 
0
 
0
 
1
 
-
 
0
 
8
 
0
 
2
 
1
 
-
 
0
 
0
 
1
 
0
 
4
 
1
 
-
 
0
 
2
 
1
 
0
 
6
 
1
 
-
 
0
 
4
 
1
 
Fatty Acid Uptake % Increase 
FIGURE 5 The ensemble of models were screened according to experi-
mentally verified Km values. (A) 1  106 models were initially generated
as described in Materials and Methods and models with physiologically rele-
vant kinetic parameters were retained. Approximately 150 models were typi-
cally retained. (B) Screening by Km results in a more quantitatively accurate
prediction of fatty acid uptake. The term ‘‘EM, Km screen’’ refers to EM
Ensemble Modeling of Hepatic Glyoxylate Shunt Expression 1393glyoxylate shunt perturbation on extracellular uptake fluxes.
For this analysis we choose to use the reference state
(PC/PYRT: 0.5, CTP/CS: 0.29), which was previously found
to predict the most accurate increase in fatty acid and
decrease in glucose uptake after glyoxylate shunt expression.
Interestingly, we found that EM more accurately captures
the increased fatty acid uptake observed in ACE cells
when this regulation is included in the model (Fig. 4 A).
After perturbing the glyoxylate shunt in this reference state
with Malate-HK2 regulation removed we did not find a pre-
dicted decrease in glucose uptake (Fig. 4 B) or in lactate
production (Fig. 4 C). Taken together, this analysis shows
that both the flux through ME1 and the regulatory properties
of malate may be necessary for the ACE phenotype.
Importance of screening the ensemble of models
by Km
To retain models with physiologically relevant kinetic
parameters, we screened the models of each ensemble for
those with Km values matching experimentally determined
values. Models matching experimentally determined Km
values (40) for glucose-6-phosphate isomerase (GPI, Km ¼
0.445 mM), phosphoglyceratemutase (PGAM, Km ¼
0.22 mM), enolase (ENO, Km ¼ 0.30 mM), and aconitase1
(ACO1, Km ¼ 0.30 mM) were retained and used to investi-
gate the effects of glyoxylate shunt perturbation. Initially,
106 models were generated for each reference state and
models with desired Km values, typically ~150, were retained
for further analysis (Fig. 5 A). To test whether this screening
step improved the capacity of EM to quantitatively predict
phenotypes we analyzed the effects of glyoxylate shunt
expression by perturbing 148 models (PC/PYRT: 0.5,
CTP/CS: 0.29) that had not been screen according to physi-
ologically relevant Km values. We found that omitting this
Km screening step resulted in a predicted fatty acid uptake
rate that was not as accurate as when the Km screening was
used (Fig. 5 B). Additionally, a two-sample Kolmogorov-
Smirnov test (41) demonstrated that distribution of fatty acid
uptake rates between ensembles that were perturbed with and
without Km screening was significantly different with >95%
confidence (p-value ¼ 0.0145). These results indicate that
the screening based on known kinetic parameters did
improve the model, and that more experimentally deter-
mined kinetic parameters will further improve the model.
prediction without any Km model screening, whereas the ‘‘EM, þKm’’
screen refers to EM prediction with models screened according to relevant
Km parameters, as described in Screening of Models by Michaelis-Menten
Constant Km. (C) The distribution of fatty acid uptake rates between ensem-
bles that were perturbed with and without Km screening was significantly
different with >95% confidence (p-value ¼ 0.0145).DISCUSSION
We have previously shown that hepatic glyoxylate shunt
expression increases fatty acid oxidation both in vitro and
in vivo. This nonnative pathway provides an additional
channel for acetyl-CoA oxidation and decreases malonyl-
CoA levels in the liver. Inspecting the pathway stoichiometry
showed that the outcome of glyoxylate shunt expression
cannot be intuitively predicted: it may lead to an increase,decrease, or no change in fatty acid degradation based on
how the pathway integrates into the host metabolic structure.
In this work we use EM to further investigate the effect of
hepatic glyoxylate shunt expression. We found that currentBiophysical Journal 98(8) 1385–1395
1394 Dean et al.mechanisms of glucose and fatty acid metabolism were not
able to describe the observed phenotypes even qualitatively,
despite exhaustive sampling of kinetic parameters. This
finding led us to the discovery that addition of malate to
the extracellular cell medium decreased HK2 gene expres-
sion. By including this regulation in EM’s regulatory net-
work we were able to describe the decrease in glucose uptake
observed in ACE cells.
We further showed that the predicted change in extracel-
lular and intracellular fluxes was a function of reference state
PC/PYRT and CTP/CS split ratios. Specifically, we found
that reference states with low (<0.1) CTP/CS split ratios
predict no change in either fatty acid or glucose uptake.
Conversely, a reference state was identified (PC/PYRT:
0.5, CTP/CS: 0.29) which predicted a 58% increase in fatty
acid uptake, closely matching the 70% measured experimen-
tally. This reference state also predicted a 40% decrease in
glucose uptake after glyoxylate shunt perturbation, which
is accurate when compared to the 47% decrease observed
experimentally. Examining the change in internal fluxes
after glyoxylate shunt perturbation showed that increased
ME1 flux was necessary for the increased fatty acid uptake
observed in ACE cells. This result was also supported by
an RNAi knockdown experiment (10). The increase in
ME1 flux was inversely proportional to glucose uptake.
This finding explains the importance of the malate-HK2
regulation. When ME1 flux increases, malate concentration
presumably increases, which reduces HK2 gene expression.
By including this regulation in EM’s regulatory network we
were able to describe the decrease in glucose uptake
observed in ACE cells. Additionally, in this work we show
that screening the ensemble of models by experimentally
determined Km values improves the predictive capacity.
This work demonstrates that EM is a suitable tool for
studying metabolic perturbations by enzyme expression
tuning, such as gene overexpression, RNAi knockdown, or
introducing a synthetic pathway (42). The effect of these
manipulations depends on the physiological context, namely
the kinetic parameters for other enzymes in the network.
As these parameters are never completely available, a frame-
work dealing with unknown parameters by sampling is
necessary. Previously, Wang et al. (18) developed a method
for performing metabolic control analysis under uncertainty.
This work allows the examination of small changes of
enzymes, as the analysis is based on linearization of models.
EM uses a full mechanistic model without linearization, and
allows the investigation of any changes in the system.
By extensive sampling of parameters in all allowable ranges,
the investigator can examine whether the current mechanism
is sufficient to describe the available data. The EM can also
predict the behavior for future perturbations, thus generating
hypotheses for testing. The disadvantage of EM, however,
resides in the large parameter space and the relatively long
computation time (hours to days on personal computers).
The limitation of EM can be overcome by further improve-Biophysical Journal 98(8) 1385–1395ment of EM algorithms and by using the ever-increasing
computing capability.SUPPORTING MATERIAL
Six tables are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(10)00009-3.REFERENCES
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